<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">BECAPLERMIN</span><br/>(be-cap'ler-min)<br/><span class="topboxtradename">Regranex<br/></span><b>Classifications:</b> <span class="classification">hormones and synthetic substitutes</span>; <span class="classification">growth factor</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>100 mcg/g gel</p>
<h1><a name="action">Actions</a></h1>
<p>Recombinant human platelet-derived growth factor B in a topical gel. It induces fibroblast proliferation.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Becaplermin enhances formation of new granulation tissue. It is effective against diabetic neuropathic ulcers that involve
         subcutaneous or deeper tissue and also have an adequate blood supply.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Lower-extremity diabetic neuropathic ulcers.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to drug or any component in formulation; neoplasms at site of application; wounds that close by primary intention;
         lactation.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Concurrent use of corticosteroids, cancer chemotherapy, or other immunosuppressive agents; ulcer wounds related to arterial
         or venous insufficiency; thermal, electrical, or radiation burns at wound site; malignancy; pregnancy (category C).
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Diabetic Neuropathic Ulcers</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Topical</span> Calculate the length of gel based on ulcer size and apply once/d until healed<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Topical</span><br/><ul>
<li>Squeeze calculated length of gel onto clean, firm, nonabsorbable surface.</li>
<li>Apply even layer to ulcer area with clean tongue depressor or cotton swab and cover with saline-moistened dressing. After
            12 h, remove dressing, clean ulcer by rinsing with water or saline to remove residual gel, and apply new saline-moistened
            dressing without becaplermin for next 12 h. Repeat cycle.
         </li>
<li>Apply only to ulcers with good blood supply.</li>
<li>Dosage calculation: Measure greatest length (<i>L</i>) and greatest width (<i>W</i>) of ulcer in inches or centimeters; using 15- or 7.5-g tube multiply (<i>L</i> <small>x</small> <i>W</i>) <small>x</small> 0.6 for dose in inches or (<i>L <small>x</small> W</i>)/4 for dose in cm; using 2-g tube multiply (<i>L <small>x</small> W</i>) <small>x</small> 1.3 for dose in inches or (<i>L <small>x</small> W</i>)/2 for dose in cm.
         </li>
<li>Recalculate weekly/biweekly the amount of drug needed.</li>
<li>Store at 2°8° C (36°46° F). Do not freeze and do not use beyond expiration date.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Skin:</span> Erythematous rash. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> <a name="nursing"><span class="implictitle">Nursing Implications</span></a>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Therapeutic effectiveness: 30% decrease in ulcer size after 10 wk or complete healing after 20 wk.</li>
<li>Monitor for and report appearance of erythematous rash.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Consult wound care provider who typically recalculates dosage weekly/biweekly.</li>
<li>Follow directions for application carefully. Gel may be measured out on waxed paper.</li>
<li>Wash hands prior to application and do not allow tip of tube to contact ulcer or any surface.</li>
<li>Report worsening ulceration or development of skin rash.</li>
<li>Do not breast feed while using this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>